Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies

Journal of Neurochemistry

Volumn 71, Issue 1, 1998, Pages 302-312

  Lyras, Leonidas ^a   Perry, Robert H ^b   Perry, Elaine K ^b   Ince, Paul G ^b   Jenner, Andrew ^a   Jenner, Peter ^a   Halliwell, Barry ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b NEWCASTLE GENERAL HOSPITAL   (United Kingdom)

Author keywords

Alzheimer's disease; Dementia with Lewy bodies; Lipid peroxidation; Oxidative stress; Oxidized DNA bases; Protein carbonyls

Indexed keywords

2,6 DIAMINO 5 FORMAMIDO 4 PYRIMIDINONE; 5 HYDROXYCYTOSINE; 5 HYDROXYMETHYLURACIL; 5 HYDROXYURACIL; 5,6 DIHYDRO 5,6 DIHYDROXYTHYMINE; 8 HYDROXYGUANINE; CARBONYL DERIVATIVE; CYTOSINE DERIVATIVE; DNA; LIPID; PEROXYNITRITE; PROTEIN; PYRIMIDINE DERIVATIVE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; THYMINE DERIVATIVE; UNCLASSIFIED DRUG; URACIL DERIVATIVE; XANTHINE;

ADULT; AGED; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DEMENTIA; DNA DAMAGE; FRONTAL LOBE; HUMAN; HUMAN TISSUE; LEWY BODY; LIPID PEROXIDATION; OCCIPITAL LOBE; OXIDATIVE STRESS; PARIETAL LOBE; PRIORITY JOURNAL; TEMPORAL LOBE;

EID: 0031842223     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.1998.71010302.x     Document Type: Article

References (58)

1. Alam Z. I., Jenner A., Daniel S. E., Lees A. J., Cairns N., Marsden C. D., Jenner P., and Halliwell B. (1997a) Oxidative DNA damage in the parkinsonian brain: a selective increase in 8-hydroxyguanine in substantia nigra? J. Neurochem. 69, 1196-1203.
2. Alam Z. I., Daniel S. E., Lees A. J., Marsden D. C., Jenner P., and Halliwell B. (1997b) A generalised increase in protein carbonyls in the brain in Parkinson's disease but not incidental Lewy body disease. J. Neurochem. 69, 1326-1329.
3. Amici A., Levine L., Tsai L., and Stadtman E. R. (1989) Conversion of amino acid residues in proteins and amino acid homopolymers to carbonyl derivatives by metal-catalysed oxidation reactions. J. Biol. Chem. 264, 3341-3346.
4. Aronson M. K., Ooi W. L., Geva D. L., and Masur D. (1991) Dementia: age-dependent incidence, prevalence and mortality in the old. Arch. Intern. Med. 151, 989-992.
5. Balazs L. and Leon M. (1994) Evidence of an oxidative challenge in the Alzheimer's brain. Neurochem. Res. 19, 1131-1137.
6. Beal M. F. (1997) Oxidative damage in neurodegenerative diseases. Neuroscientist 3, 21-27.
7. Canadian Study of Health and Aging Working Group (1994) Canadian study of health and aging : study methods and prevalence of dementia. Can. Med. Assoc. J. 150, 899-913.
8. Chirico S., Smith C., Marchant C., Mitchinson M. J., and Halliwell B. (1993) Lipid peroxidation in hyperlipidemic patients. A study of plasma using an HPLC-based thiobarbituric acid test. Free Radic. Res. Commun. 19, 51-57.
9. Cruz-Sanchez F. F., Ravid R., and Cuzner M. L., eds (1995) Biomedical and Health Research, Vol. 10: Neuropathological Diagnostic Criteria for Brain Banking. IOS Press, Oxford.
10. Dean R. T., Fu S., Stocker R., and Davies M. J. (1997) Biochemistry and pathology of radical-mediated protein oxidation. Biochem. J. 324, 1-18.
11. Dexter D. T., Carter C. J., Wells F. R., Javoy-Agid F., Agid Y., Lees A., Jenner P., and Marsden C. D. (1989) Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52, 381-389.
12. Dexter D. T., Carayon A., Javoy-Agid F., Agid Y., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden C. D. (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114, 1953-1975.
13. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., and Marsden C. D. (1994) Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: an HPLC and ESR study. Mov. Disord. 9, 92-97.
14. Dizdaroglu M. (1994) Chemical determination of oxidative DNA damage by GC-MS. Methods Enzymol. 234, 3-16.
15. Floor E. and Wetzel M. G. (1998) Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay. J. Neurochem. 70, 268-275.
16. Friedlich A. L. and Butcher L. L. (1993) Involvement of free oxygen radicals in β-amyloidosis: an hypothesis. Neurobiol. Aging 15, 443-455.
17. Frölich L. and Riederer P. (1995) Free radical mechanisms in dementia of Alzheimer type and the potential for anti-oxidative treatment. Arzneimittelforschung 45, 443-446.
18. Gibb W. R. G. and Lees A. J. (1988) The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J. Neurol. Neurosurg. Psychiatry 51, 745-752.
19. Gotz M. E., Kunig G., Riederer P., and Youdim M. B. H. (1994) Oxidative stress: free radical production in neuronal degeneration. Pharmacol. Ther. 63, 37-122.
20. Gsell W., Conrad R., Hickethier M., Sofic E., Frölich L., Wichart I., Jellinger K., Moll G., Ransmayr G., Beckmann H., and Riederer P. (1995) Decreased catalase activity but unchanged superoxide dismutase activity in brains of patients with dementia of Alzheimer type. J. Neurochem. 64, 1216-1223.
21. Halliwell B. (1992) Reactive oxygen species and the central nervous system. J. Neurochem. 59, 1609-1623.
22. Halliwell B. (1996) Oxidative stress, nutrition and health. Experimental strategies for optimization of nutritional antioxidant intake in humans. Free Radic. Res. 25, 57-74.
23. Halliwell B. and Dizdaroglu M. (1992) The measurement of oxidative damage to DNA by HPLC and GC/MS techniques. Free Radic. Res. Commun. 16, 75-87.
24. Hansen L. A., Salmon D., Galasko D., Masliah E., Katzman R., De Teresa R., Thal L., Pay M. M., Hofstetter R., Klauber M., et al. (1990) The Lewy body variant of Alzheimer's disease: a clinical and pathologic entity. Neurology 40, 1-8.
25. Harman D. (1993) Free radical theory of aging: a hypothesis on pathogenesis of senile dementia of the Alzheimer's type. Age 16, 23-30.
26. Jeding I., Evans P. J., Akanmu D., Dexter D., Spencer J. P. E., Aruoma O. I., Jenner P., and Halliwell B. (1995) Characterization of the potential antioxidant and pro-oxidant actions of some neuroleptic drugs. Biochem. Pharmacol. 49, 359-365.
27. Jenner P. and Olanow C. W. (1996) Oxidative stress and the pathogenesis of Parkinson's disease. Neurology 47 (Suppl. 3), S161-S170.
28. Jenner A., England T. G., Aruoma O. I., and Halliwell B. (1998) Measurement of oxidative DNA damage by gas chromatography-mass spectrometry. The use of ethanethiol to prevent artefactual generation of oxidised DNA bases. Biochem. J. 331, 365-369.
29. Kontour P. J., Al-Tikriti M., Innis R. B., and Roth R. H. (1994) Postmortem stability of monoamines, their metabolites, and receptor binding in rat brain regions. J. Neurochem. 62, 282-290.
30. Kosaka K., Yoshimura M., Ikeda K., and Budka H. (1984) Diffuse type of Lewy body disease: progressive dementia with abundant conical Lewy bodies and senile changes of varying degree: a new disease? Clin. Neuropathol. 3, 185-192.
31. Lennox G., Lowe J., Morrell R., Landon M., and Mayer R. J. (1989) Anti-ubiquitin immunocytochemistry is more sensitive than conventional techniques in the detection of diffuse Lewy body disease. J. Neurol. Neurosurg. Psychiatry 52, 67-71.
32. Levine R. L., Garland D., Oliver C. N., Amici A., Climent I., Lenz A. G., Ahn B. W., Shaltiel S., and Stadtman E. R. (1990) Determination of carbonyl content in oxidatively modified proteins. Methods Enzymol. 186, 464-487.
33. Levine R. L., Williams J. A., Stadtman E. R., and Shacter E. (1994) Carbonyl assays for determination of oxidatively modified proteins. Methods Enzymol. 233, 346-357.
34. Lovell M. A., Ehmann W. D., Butler S. M., and Markesbery W. R. (1995) Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease. Neurology 45, 1594-1601.
35. Lyras L., Evans P. J., Shaw P. J., Ince P. G., and Halliwell B. (1996) Oxidative damage and motor neurone disease. Difficulties in the measurement of protein carbonyls in human brain tissue. Free Radic. Res. 24, 397-406.
36. Lyras L., Cairns N. J., Jenner A., Jenner P., and Halliwell B. (1997) An assessment of oxidative damage to proteins, lipids, and DNA in brain from patients with Alzheimer's disease. J. Neurochem. 68, 2061-2069.
37. Markesbery W. R. (1997) Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23, 134-147.
38. Martins N. P., Harper C. G., Stokes G. B., and Masters C. L. (1986) Increased cerebral glucose-6-phosphate dehydrogenase activity in Alzheimer's disease may reflect oxidative stress. J. Neurochem. 46, 1042-1045.
39. McKeith I. G., Galasko D., Kosaka K., Perry E. K., Dickson D. W., Hamsen L. A., Salmon D. P., Lowe J., Mirra S. S., Byrne E. J., Lennox G., Quinn N. P., Edwardson J. A., Ince P. G., Bergeron C., Burns A., Miller B. L., Lovestone S., Collerton D., Jansen E. N. H., Ballard C., de Vos R. A. I., Wilcock G. K., Jellinger K. A., and Perry R. H. (1996) Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 47, 1113-1124.
40. Mecocci P., MacGarvey U., and Beal M. F. (1994) Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease. Ann. Neurol. 36, 747-751.
41. Nixon R. A. and Cataldo A. M. (1994) Free radicals, proteolysis and the degeneration of neurons in Alzheimer disease: how essential is the β-amyloid link? Neurobiol. Aging 15, 463-469.
42. Oestreicher E., Sengstock G. J., Riederer P., Olanow C. W., Dunn A. J., and Arendash G. (1994) Degeneration of nigrostriatal dopaminergic neurons increases iron within the substantia nigra: a histochemical and neurochemical study. Brain Res. 660, 8-18.
43. Owen A. D., Schapira A. H. V., Jenner P., and Marsden C. D. (1996) Relevance of Lewy bodies to alterations in oxidative stress in Lewy body dementia and Parkinson's disease, in Dementia with Lewy Bodies: Clinical, Pathological and Treatment Issues (Perry R., McKeith I., and Perry E., eds), pp. 477-486. Cambridge University Press, Cambridge.
44. Palmer A. M. and Burns M. A. (1994) Selective increase in lipid peroxidation in the inferior temporal cortex in Alzheimer's disease. Brain Res. 645, 338-342.
45. Perry R. H., Irving D., Blessed G., Fairbairn A., and Perry E. K. (1990) Senile dementia of Lewy body type. A clinically and neuropathologically distinct type of Lewy body dementia in the elderly. J Neurol. Sci. 95, 119-139.
46. 4. Biochem. J. 264, 527-532.
47. Ravanat J. L., Turesky R. J., Gremaud E., Trudel L. J., and Stadler R. H. (1995) Determination of 8-oxyguanine in DNA by gas chromatography-mass spectrometry and HPLC-electrochemical detection: overestimation of the background level of the oxidised base by the gas chromatography-mass spectrometry assay. Chem. Res. Toxicol. 8, 1039-1045.
48. Reznick A. Z. and Packer L. (1994) Oxidative damage to proteins: spectrophotometric method for carbonyl assay. Methods Enzymol. 223, 357-363.
49. Saggu H., Cooksey J., Dexter D. T., Wells F. R., Lees A., Jenner P., and Marsden C. D. (1989) A selective increase in particulate Superoxide dismutase activity in parkinsonian substantia nigra. J. Neurochem. 53, 692-697.
50. Sanchez-Ramos J., Overvik E., and Ames B. N. (1994) A marker of oxyradical-mediated DNA damage (8-hydroxy-2′-deoxyguanosine) is increased in nigrostriatum of Parkinson's disease brain. Neurodegeneration 3, 197-204.
51. Smith C. D., Carney J. M., Starke-Reed P. E., Oliver C. N., Stadtman E. R., Floyd R. A., and Markesbery W. R. (1991) Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc. Natl. Acad. Sci. USA 88, 10540-10543.
52. Smith M. A., Sayre L. M., Anderson V. E., Beal M. F., Kowall N., Richey P. L., and Perry G. (1996) Oxidative damage in Alzheimer's. Nature 382, 120-121.
53. Spencer J. P. E., Jenner A., Aruoma O. I., Evans P. J., Kaur H., Dexter D. T., Jenner A., Lees A. J., Marsden D. C., and Halliwell B. (1994) Intense oxidative damage promoted by L-DOPA and its metabolites. Implications for neurodegenerative disease. FEBS Lett. 353, 246-250.
54. Spencer J. P. E., Wong J., Jenner A., Aruoma O. I., Cross C. E., and Halliwell B. (1996a) Base modification and strand breakage in isolated calf thymus DNA and in DNA from human epidermal keratinocytes exposed to peroxynitrite or 3-morpholinosydnonimine. Chem. Res. Toxicol. 19, 1152-1158.
55. Spencer J. P. E., Jenner A., Butler J., Aruoma O. I., Dexter D. T., Jenner P., and Halliwell B. (1996b) Evaluation of the prooxidant and antioxidant actions of L-DOPA and dopamine in vitro: implications for Parkinson's disease. Free Radic. Res. 24, 95-105.
56. Thierry D., Bianchinni F., and Cadet J. (1996) Observation and prevention of an artefactual formation of oxidized DNA bases and nucleosides in the GC-EIMS method. Carcinogenesis 17, 347-353.
57. Yoritaka A., Hattori N., Uchida K., Tanaka M., Stadtman E. R., and Mizuno Y. (1996) Immunohistochemical detection of 4-hydroxynonenal protein adducts in Parkinson's disease. Proc. Natl. Acad. Sci. USA 93, 2696-2713.
58. Youdim M. B. H., Ben-Shachar D., and Riederer P. (1993) The possible role of iron in the etiopathology of Parkinson's disease. Mov. Disord. 8, 1-12.